The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in sales , its intellectual property lapse created a deluge of lower-priced alternatives , significantly eroding its position . While certain pharmaceutical companies may seek to capitalize on relat